MedTrace Logo

Relative Energy Deficiency in Sport Multicenter Study

NCT04766203 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2000

Last updated 2021-06-02

No results posted yet for this study

Summary

Relative Energy Deficiency in Sport (RED-S) characterizes a range of negative health and performance outcomes that result from chronically low energy availability. RED-S concerns high performance junior and senior athletes across Canada and has a prevalence rate of 3-60%. Our ability to assess and diagnose RED-S remains poor. Accordingly, we aim to create the best parameters to diagnose and manage RED-S; along with information of the prevalence and severity across Canada and globally. These outcomes are expected to have a significant positive impact on the health and performance of Canadian athletes in preparation for the Olympic Games in 2022 and beyond.

Conditions

  • Health, Subjective
  • Nutrition Disorders
  • Athletic Injuries
  • Hormone Disturbance
  • Exercise-related Amenorrhea
  • Eating Disorders
  • Sleep Hygiene
  • Cardiovascular Abnormalities
  • Bone Fracture
  • Bone Loss
  • Weight Change, Body
  • Mental Health Wellness 1

Interventions

BEHAVIORAL

Treatment of REDS using a holistic treatment arm

This arm aims to treat athletes with REDS symptoms by implementing a holistic, individualized nutrition intervention to improve energy availability and thus restore impaired body function due to REDS.

Sponsors & Collaborators

  • Mitacs

    collaborator INDUSTRY

  • University of British Columbia

    collaborator OTHER

  • Trent Stellingwerff

    lead OTHER

Principal Investigators

  • Trent Stellingwerff, Ph.D. · Canadian Sport Institute Pacific, University of Victoria, University of British Columbia

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-05
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04766203 on ClinicalTrials.gov